| Literature DB >> 27324469 |
Xingfu Jiang1, Lei Zhang1, Haixia Yang1,2, Thomas W Sappington3, Yunxia Cheng1, Li Zhi Luo1,2.
Abstract
Tritrophic interactions between Mythimna separata, its tachinid parasite Exorista civilis and the Cry1Ab were examined. Although 6th instar M. separata mortality increased with increasing Cry1Ab concentration, some tolerance was evident. Likewise, parasitization by E. civilis resulted in only 18% host mortality. However, combination of Cry1Ab and E. civilis parasitization resulted in a significant Cry1Ab dose-dependent increase in mortality over that of either alone, including a 50-56% synergistic increase in efficacy at the two concentrations tested. Pupal weight, adult emergence and lifetime fecundity of M. separata derived from larvae surviving both agents were negatively affected. The ability of E. civilis to parasitize and subsequently develop on the host was not adversely influenced by Cry1Ab. Instead, pupation rate increased significantly among host larvae fed 3.125 μg/g Cry1Ab diet. Overall, our results demonstrate that use of Cry1Ab to control M. separata not only is compatible with the use of the tachinid parasitoid, but that the two methods can act synergistically to manage this destructive pest, provide support for the safety of transgenic Cry1Ab Bt plants in China. This example of two independent pest management strategies acting synergistically against a difficult pest offers a new perspective of broad significance in striving for agricultural sustainability.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27324469 PMCID: PMC4914922 DOI: 10.1038/srep26873
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Mortality of 6th instar M. separata fed on artificial diet containing different concentrations of Cry1Ab when unparasitized (A) or parasitized (B) by the tachinid fly E. civilis. Larvae comprising the CK group in panel B were not exposed to either Cry1Ab or parasitism. Data are presented as mean ± SEM. Bars sharing the same letter are not significantly different at 5% level by Tukey’s HSD test. Sample sizes of each treatment in panel A are 90. Sample sizes in panel B are 168, 229, 167, 150, 170 and 189 from left to right, respectively.
Regressions of 6th instar M. separata mortality against Cry1Ab concentration in artificial diet, and LC50s, when unparasitized or parasitized by E. civilis.
| Chi-square(χ2) | LC50 and 95% CI (μg/g) | ||||
|---|---|---|---|---|---|
| Unparasitized | 1.310 | −1.376 | 4.405 | 0.221 | 11.243 (6.767–15.622) |
| Parasitized | 1.156 | −0.312 | 2.872 | 0.238 | 1.863 (0.891–2.813) |
Pupal and reproductive performance of M. separata surviving both parasitism by E. civilis and consumption of larval diet containing different concentrations of Cry1Ab protoxin.
| Cry1Abconcentrations(μg/g) | Pupationrate (%) | Pupal weight(mg) | Pupal period (days) | Emergencerate (%) | Preovipositionperiod (days) | Total no. eggslaid in lifetime |
|---|---|---|---|---|---|---|
| CK | 98.1 (162) | 310.6 ± 7.3(46) a | 11.8 ± 0.2 (54) a | 95.0 (159) | 5.0 ± 0.2 (20) a | 1171 ± 50 (20) a |
| 0 | 94.1 (187) | 252.6 ± 7.8(39) b | 11.9 ± 0.2 (54) a | 56.3 (176) | 6.9 ± 0.3 (17) b | 790 ± 39 (17)b |
| 3.125 | 84.8 (59) | 219.4 ± 7.9(26) b | 12.2 ± 0.3 (16) a | 36.0 (50) | 7.5 ± 0.7 (4) b | 761 ± 77 (4) b |
| 6.25 | 84.6 (26) | 227.2 ± 6.2(22) b | 12.0 ± 0.3 (6) a | 27.3 (22) | 8.3 ± 0.3 (3) b | 734 ± 39 (3) b |
| 12.5 | 64.0 (25) | 180.7 ± 6.3(13) c | 11.0 ± 0.3 (6) a | 25.0 (16) | No pairs were set up to mate | – |
| 25 | 68.8 (16) | 136.1 ± 7.9(12) d | No pupae survived | – | – | – |
CK indicates neither Cry1Ab nor parasitism. Number in the parentheses indicates the corresponding sample size. Data are presented as mean ± SEM. In each column, data sharing the same letter are not significantly different at 5% level by Tukey’s HSD test or Chi-squared tests.
Figure 2Influence of Cry1Ab concentrations in the host (M. separata) larval diet on parasitism rate (A), pupation rate (B), emergence rate (C) and life time fecundity (D) of the tachinid parasitoid, E. civilis. Data are presented as mean ± SEM. Bars sharing the same letter are not significantly different at 5% level by Tukey’s HSD test. Sample sizes (left to right) for each treatment are 51, 49, 46, 50 and 42 (A); 229, 182, 240, 273 and 418 (B); 39, 60, 36, 41 and 46 (C); and 17, 22, 15, 14, and 14 (D), respectively.